Immunochemical detection of Nε-(carboxyethyl)lysine using a specific antibody

Journal of Immunological Methods

Volumn 332, Issue 1-2, 2008, Pages 112-120

  Nagai, Ryoji ^a   Fujiwara, Yukio ^a   Mera, Katsumi ^a   Yamagata, Kazuya ^a   Sakashita, Naomi ^a   Takeya, Motohiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AGE; Embden Meyerhof pathway; Methylglyoxal; N (carboxyethyl)lysine (CEL); N (carboxymethyl)lysine (CML)

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; CARBOCISTEINE; GLYOXAL; HUMAN SERUM ALBUMIN; METHYLGLYOXAL; MONOCLONAL ANTIBODY; N EPSILON (CARBOXYETHYL)LYSINE; POLYCLONAL ANTIBODY; RIBONUCLEASE; UNCLASSIFIED DRUG; ALDEHYDE; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; SERUM ALBUMIN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; CATTLE; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KIDNEY; METHODOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; WISTAR RAT;

BOVINAE; RATTUS;

ALDEHYDES; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LYSINE; MALE; PYRUVALDEHYDE; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN;

EID: 40649129674     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2007.12.020     Document Type: Article

References (25)

1. Ahmed M.U. Brinkmann Frye E. Degenhardt T.P. Thorpe S.R. Baynes J.W. N -epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins Biochem. J. 324 Pt 2 1997 565
2. Alderson N.L. Chachich M.E. Frizzell N. Canning P. Metz T.O. Januszewski A.S. Youssef N.N. Stitt A.W. Baynes J.W. Thorpe S.R. Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in the streptozotocin diabetic rat Diabetologia 47 2004 1385
3. Babaei-Jadidi R. Karachalias N. Ahmed N. Battah S. Thornalley P.J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine Diabetes 52 2003 2110
4. Degenhardt T.P. Thorpe S.R. Baynes J.W. Chemical modification of proteins by methylglyoxal Cell. Mol. Biol. (Noisy-le-grand) 44 1998 1139
5. Degenhardt T.P. Alderson N.L. Arrington D.D. Beattie R.J. Basgen J.M. Steffes M.W. Thorpe S.R. Baynes J.W. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney Int. 61 2002 939
6. Fu M.X. Requena J.R. Jenkins A.J. Lyons T.J. Baynes J.W. Thorpe S.R. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions J. Biol. Chem. 271 1996 9982
7. Hammes H.P. Du X. Edelstein D. Taguchi T. Matsumura T. Ju Q. Lin J. Bierhaus A. Nawroth P. Hannak D. Neumaier M. Bergfeld R. Giardino I. Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy Nat. Med. 9 2003 294
8. Horiuchi S. Araki N. Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure J. Biol. Chem. 266 1991 7329
9. Iijima K. Murata M. Takahara H. Irie S. Fujimoto D. Identification of N (omega)-carboxymethylarginine as a novel acid-labileadvanced glycation end product in collagen Biochem. J. 347 Pt 1 2000 23
10. Ikeda K. Higashi T. Sano H. Jinnouchi Y. Yoshida M. Araki T. Ueda S. Horiuchi S. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction Biochemistry 35 1996 8075
11. Imai N. Nishi S. Suzuki Y. Karasawa R. Ueno M. Shimada H. Kawashima S. Nakamaru T. Miyakawa Y. Araki N. Horiuchi S. Gejyo F. Arakawa M. Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy Nephron 76 1997 153
12. Jono T. Nagai R. Lin X. Ahmed N. Thornalley P.J. Takeya M. Horiuchi S. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone J. Biochem. (Tokyo) 136 2004 351
13. Koito W. Araki T. Horiuchi S. Nagai R. Conventional antibody against Ne-(Carboxymethyl)lysine (CML) shows cross-reaction to Ne-(Carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody J. Biochem. (Tokyo) 136 2004 831
14. Kume S. Takeya M. Mori T. Araki N. Suzuki H. Horiuchi S. Kodama T. Miyauchi Y. Takahashi K. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody Am. J. Pathol. 147 1995 654
15. McLellan A.C. Thornalley P.J. Benn J. Sonksen P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications Clin. Sci. (Lond) 87 1994 21
16. Miyata T. Oda O. Inagi R. Iida Y. Araki N. Yamada N. Horiuchi S. Taniguchi N. Maeda K. Kinoshita T. Beta 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis J. Clin. Invest. 92 1993 1243
17. Nagai R. Ikeda K. Higashi T. Sano H. Jinnouchi Y. Araki T. Horiuchi S. Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product Biochem. Biophys. Res. Commun. 234 1997 167
18. Nagai R. Matsumoto K. Ling X. Suzuki H. Araki T. Horiuchi S. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor Diabetes 49 2000 1714
19. Nagai R. Hayashi C.M. Xia L. Takeya M. Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins J. Biol. Chem. 277 2002 48905
20. Nagai R. Unno Y. Hayashi M.C. Masuda S. Hayase F. Kinae N. Horiuchi S. Peroxynitrite induces formation of N (epsilon)-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite Diabetes 51 2002 2833
21. Nagai R. Araki T. Hayashi C.M. Hayase F. Horiuchi S. Identification of N epsilon-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 788 2003 75
22. Phillips S.A. Thornalley P.J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal Eur. J. Biochem. 212 1993 101
23. Stitt A. Gardiner T.A. Alderson N.L. Canning P. Frizzell N. Duffy N. Boyle C. Januszewski A.S. Chachich M. Baynes J.W. Thorpe S.R. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2002 2826
24. Wells-Knecht K.J. Zyzak D.V. Litchfield J.E. Thorpe S.R. Baynes J.W. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose Biochemistry 34 1995 3702
25. Yamada K. Miyahara Y. Hamaguchi K. Nakayama M. Nakano H. Nozaki O. Miura Y. Suzuki S. Tuchida H. Mimura N. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure Clin. Nephrol. 42 1994 354